Navigation Links
Using coxibs and NSAIDs to treat osteoarthritis
Date:8/13/2007

Mt Laurel, NJ 13 August 2007 - In an Editorial, to be published in the international journal Osteoarthritis and Cartilage (http://intl.elsevierhealth.com/journals/joca/), published by Elsevier, a panel of arthritis research experts has recommended that coxibs and nonsteroidal anti-inflammatory drugs (NSAIDs) must remain a significant part of the tool kit used in treating osteoarthritis (OA). The Editorial summarizes the outcomes of an international workshop organized by the Osteoarthritis Research Society International (OARSI) and the International COX-2 Study Group, held 2425 March 2007. The authors urge that an evidence-based approach must be taken when making recommendations to patients.

OA, the most common form of arthritis, is a major medical problem. It has been estimated that over 20 million Americans are afflicted with OA, and that number will rise to 40 million by the year 2020. Controversy now exists as to the safest and most efficacious way of treating the disease, particularly with respect to use of NSAIDs, both non-selective and selective (so-called COX-2 selective agents or coxibs). Adverse reactions related to the gastrointestinal tract, particularly with the non-selective NSAIDs, have been described; more recently, concerns have been expressed related to the cardiovascular system with both groups of agents.

A recent scientific statement from the American Heart Association (AHA) made recommendations with regard to the treatment of OA.1 A number of these recommendations are challenged in the Editorial2 in Osteoarthritis and Cartilage, with particular concern about their impact on appropriate use of these agents.

The Editorial questions the recommendation made in the AHA statement which described a stepped care approach to pharmacologic therapy for musculoskeletal diseases. The Editorial strongly recommends that several aspects of the AHA statement be reconsi
'/>"/>

Contact: Ian Salusbury
ian.salusbury@elsevier.com
44-186-584-3000
Elsevier
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Poor health care in Russia maybe causing Decline in its Population
2. Multi billion-dollar suit filed against cell phone firm for causing brain tumours
3. Researchers urge caution in using ear tube surgery
4. Ulcer causing bug found in stored food
5. Using Stem Cells To Treat Incontinence In Women
6. Flu-Drugs Are Causing Resistance Across The World
7. Researchers at Cornell University as been reported using research fund by false claims
8. Relief to pregnant women using fertility drugs
9. The hazards of using disinfectant hand gel
10. Colon cancer risk linked to genes causing Hemochromatosis
11. Teens Misusing Nicotine-Replacement Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... The Fibroids Miracle review indicates that this is a new ... and powerful results. It actually claims to be able to ... 12 hours. The method promises to lead to a permanent ... on a 3 step method that has never been revealed ... was in fact created by someone who had an important ...
(Date:8/29/2014)... Daily Gossip reveals in its Stop Sciatica ... method of naturally curing this disease. , The program ... permanent cure in only one week. This is described as ... make huge sacrifices. , Moreover, with this new method ... of sciatica in just 8 minutes. , Interested customers ...
(Date:8/29/2014)... Skmen.com, a famous online supplier of trendy clothes, has unveiled ... the moment, all these mini outfits are offered at discounted ... promotion is September 14. , The company’s senior spokesman ... our hot designs, we have listed some of the best-selling ... stylish ladies to get high quality, fashionable clothes. Many of ...
(Date:8/29/2014)... Indosoft, Inc., a leading provider of scalable Asterisk-based ... licensing of its Q-Suite 5.7 software. As a ... been successfully deploying and supporting its ACD and Dialer ... the world for more than a decade. The introduction ... option which complements the widespread deployment of Q-Suite in ...
(Date:8/29/2014)... 2014 Developed as a nod to ... Canada Goose products offer the mobility, durability ... Arctic runways. The company’s Canada Goose Chilliwack bombers ... current market. Additionally, the firm has unveiled its new ... , At present, all high quality Chilliwack bombers are ...
Breaking Medicine News(10 mins):Health News:Fibroids Miracle Review Exposes Amanda Leto’s 3-Step Holistic System 2Health News:Stop Sciatica in 8 Minutes Review Exposes Steven Guo's Complete Sciatica Cure 2Health News:Cheap Sexy Mini Dresses Added To The Product Line Of Skmen.com 2Health News:Indosoft Offers Monthly Usage Licensing Terms 2Health News:New Designs Of Canada Goose Chilliwack Bombers From DoudouneCanadienneGoosePasCher.fr 2
... to raise awareness of the National Marrow Donor Program , ... ... Marrow Donor Program® (NMDP) and Preston Kelly, an independent agency in ... to increase awareness of the importance of joining the Be The ...
... EHRtv on EHR implementation and the state of Healtcare IT in ... ... 24, 2009 -- EHRtv.com, the newly launched website for Comprehensive Video ... interview Former Representative Richard Gephardt during the Recent HIMSS09 Health IT ...
... Khanna institute of Lasik gives back to the community and helps ... ... Village, CA (PRWEB) April 24, 2009 -- Oaks Christian is an ... village. Recently, The Khanna Institute supported their efforts and ...
... in the Lungs , A group led by Dr. ... as a mediator of lung fibrosis. They present their data in ... . , Scar tissue, or fibrosis, can accumulate in ... lung disease, respiratory failure, and eventually death. An increase in ...
... World Malaria Day Events Held in Nairobi , ... Washington LAUSANNE, Switzerland, ... on 4/25, ,Counting Malaria Out, Vestergaard Frandsen is stepping up ... a new version that is effective against insecticide resistant mosquitoes. Malaria ...
... might be replicated for heart disease, scientists say, , , THURSDAY, ... patient,s own skin cells to grow tissue-engineered shunts for dialysis ... The problem right now is that about half of all ... via a plastic tube that creates a shunt -- a ...
Cached Medicine News:Health News:Be The MatchSM Brand Campaign Launches 2Health News:Be The MatchSM Brand Campaign Launches 3Health News:Representative Richard Gephardt Sits Down With EHRtv.com 2Health News:Khanna Institute Supports Oaks Christian School's Annual Fundraiser 2Health News:Tips from the American Journal of Pathology 2Health News:Tips from the American Journal of Pathology 3Health News:Tips from the American Journal of Pathology 4Health News:Working Towards 'Counting Malaria Out' Through Scale-Up of PermaNet(R) Bed Nets, Vestergaard Frandsen Produces 175 Millionth Net; Introduces New Net To Combat Insecticide Resistance 2Health News:Working Towards 'Counting Malaria Out' Through Scale-Up of PermaNet(R) Bed Nets, Vestergaard Frandsen Produces 175 Millionth Net; Introduces New Net To Combat Insecticide Resistance 3Health News:First Vessel Graft Grown From Kidney Patients' Own Cells 2Health News:First Vessel Graft Grown From Kidney Patients' Own Cells 3Health News:First Vessel Graft Grown From Kidney Patients' Own Cells 4
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets ... Peptide Cancer Therapeutics Market & Pipeline Insight 2014" ... methods developed to prevent and eradicate the prevalence of ... methods are confined to low specificity, safety and large ... look for a better solution. It has been discovered ...
(Date:8/29/2014)... DALLAS , August 29, 2014 ... report, "Amaranth Seed Oil Market by Extraction type (SFE, ... (Cosmetic & Personal Care, Pharmaceutical, Food Supplements, Fragrance, & ... published by MarketsandMarkets, defines and segments the Amaranth ... of the market size in terms of value. ...
(Date:8/29/2014)... Research and Markets has announced the addition ... Pharmaceutical Equipment Market in China, 2014-2018" report to ... Forecast of Pharmaceutical Equipment Market in China ... pharmaceutical equipment industry in the aspects of current ... performance of domestic major enterprises, as well as offers ...
Breaking Medicine Technology:Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2
... 26, 2007 - Aeolus,Pharmaceuticals, Inc. (OTCBB:AOLS) announced ... issue of the Journal of Neuroscience a ... and National Jewish,Medical and Research Center demonstrating ... AEOL 11207, demonstrated,neuroprotection in an animal model ...
... adding Diovan to conventional therapy , , , Study ... , , BASEL,Switzerland, April 27, 2007 ... published today in The Lancet[1], show that,adding the blood ... 39% reduction in,cardiovascular events and a 40% reduction in ...
Cached Medicine Technology:Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 2Study Demonstrating Aeolus Compound's Neuroprotection in,Parkinson's Disease Published in the Journal of Neuroscience 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 4Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 5Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 6Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 7
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
The HT-PB is a implantable bipolar tined permanent pacing lead for stimulation of the ventricle....
Medicine Products: